Literature DB >> 29779586

Multimodality Assessment of Right Ventricular Strain in Patients With Acute Pulmonary Embolism.

Brett J Carroll1, Benedikt H Heidinger2, Dominique C Dabreo2, Jason D Matos3, Donya Mohebali3, Stephanie A Feldman4, Ian McCormick3, Diana Litmanovich2, Warren J Manning5.   

Abstract

Optimal risk stratification is essential in managing patients with an acute pulmonary embolism (PE). There are limited data evaluating the potential additive value of various methods of evaluation of right ventricular (RV) strain in PE. We retrospectively evaluated RV strain by computed tomography (CT), transthoracic echocardiography (TTE), electrocardiography (ECG), and troponin levels in consecutive hospitalized patients with acute PE (May 2007 to December 2014). Four-hundred and seventy-seven patients met inclusion criteria. RV strain on ECG (odds ratio [OR] 1.9, confidence interval [CI] 1.1 to 3.3; p = 0.03), CT (OR 2.7, CI 1.5 to 4.8, p <0.001), TTE (OR 2.8, CI 1.5 to 5.4, p <0.001), or a positive troponin (OR 2.7, CI 2.0 to 6.9, p <0.001) were associated with adverse events. In patients with ECG, CT, and TTE data, increased risk was only elevated with RV strain on all 3 parameters (OR 4.6, CI 1.8 to 11.3, p <0.001). In all patients with troponin measurements, risk was only elevated with RV strain on all 3 parameters plus a positive troponin (OR 8.8, CI 2.8 to 28.1, p <0.001) and was similar in intermediate-risk PE (OR 11.1, CI 1.2 to 103.8, p = 0.04). In conclusion, in patients with an acute PE and evaluation of RV strain by ECG, CT, and TTE, risk of adverse events is only elevated when RV strain is present on all 3 modalities. Troponin further aids in discriminating high-risk patients. Multimodality assessment of RV strain is identified as a superior approach to risk assessment.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29779586     DOI: 10.1016/j.amjcard.2018.03.013

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  5 in total

1.  CT Pulmonary Angiography for Risk Stratification of Patients with Nonmassive Acute Pulmonary Embolism.

Authors:  David C Rotzinger; Jean-François Knebel; Anne-Marie Jouannic; Ghazal Adler; Salah D Qanadli
Journal:  Radiol Cardiothorac Imaging       Date:  2020-08-27

2.  Short-term prognostic value of clinical data in hospitalized patients with intermediate-risk acute pulmonary embolism.

Authors:  Jichun Liu; Yuanyuan Liu; Feilong Zhang; Cong Fu; Yang Ling; Ping Fang; Xiangrong Xie; Xianghai Wang; Hao Yang; Youquan Wei; Jinfeng Wang
Journal:  BMC Cardiovasc Disord       Date:  2022-07-28       Impact factor: 2.174

3.  Clinical Outcomes of Patients with Intermediate-to-High-Risk Pulmonary Embolism Undergoing Ultrasound-Assisted Catheter-Based Fibrinolysis Therapy in a Mid-Term Follow-Up Period - A Retrospective Observational Study.

Authors:  Chun-Cheng Wang; Chiung-Ray Lu; Li-Chuan Hsieh; Yu-Kai Lin; Kuan-Cheng Chang; Chung-Ho Hsu
Journal:  Acta Cardiol Sin       Date:  2020-09       Impact factor: 2.672

4.  Contribution of Quick Sequential Organ Failure Assessment Score Combined with Electrocardiography in Risk Stratification of Patients with Acute Pulmonary Embolism.

Authors:  Fei Teng; Yun-Xia Chen; Xin-Hua He; Shu-Bin Guo
Journal:  Chin Med J (Engl)       Date:  2018-10-20       Impact factor: 2.628

5.  Incremental Value of ePLAR-The Echocardiographic Pulmonary to Left Atrial Ratio in the Assessment of Sub-Massive Pulmonary Emboli.

Authors:  Isabel G Scalia; William M Scalia; Jonathon Hunter; Andrea Z Riha; David Wong; Yael Celermajer; David G Platts; Benjamin T Fitzgerald; Gregory M Scalia
Journal:  J Clin Med       Date:  2020-01-17       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.